Dorothy Whelan

Healthcare | Medical Devices

Dorothy Whelan | Fish & Richardson

MCC: Fish was recently named the #1 most active law firm at the PTAB. Can you share with us the work you are doing generally in the post-grant area, and specifically how you are using IPRs in your patent and litigation strategies for life sciences companies? Whelan: After the America Invents Act (...

Technology

Dorothy Whelan, Karl Renner | Fish & Richardson

Editor: Fish is one of most active firms involved with post-grant proceedings and has played a pivotal role in shaping this important new field of IP practice. Tell us more about the work you are doing. Renner: Post-grant proceedings truly are hybrids. In response, we are creating...